Lorazepam injection
Products billed under this code include Ativan, Lorazepam.
Payment limit per 2 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J2060
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ativan | Hikma Pharmaceuticals USA Inc. | 00641-6000-10 | 100 | $219.70 |
| Ativan | Hikma Pharmaceuticals USA Inc. | 00641-6001-25 | 25 | $54.925 |
| Ativan | Hikma Pharmaceuticals USA Inc. | 00641-6002-10 | 200 | $439.40 |
| Ativan | Hikma Pharmaceuticals USA Inc. | 00641-6003-25 | 50 | $109.85 |
| Lorazepam | Pfizer Inc | 00409-1985-30 | 10 | $21.97 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6044-25 | 25 | $54.925 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6045-25 | 50 | $109.85 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6046-10 | 100 | $219.70 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6047-10 | 200 | $439.40 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6048-25 | 25 | $54.925 |
Show all 16 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6049-25 | 50 | $109.85 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6050-10 | 100 | $219.70 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6051-10 | 200 | $439.40 |
| Lorazepam | Hikma Pharmaceuticals USA Inc. | 00641-6207-25 | 25 | $54.925 |
| Lorazepam | FreseniUS Kabi USA, LLC | 65219-0368-02 | 25 | $54.925 |
| Lorazepam | Civica, Inc. | 72572-0380-25 | 25 | $54.925 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.197 | −$0.105 | 2 MG | Lorazepam injection | v1, posted September 17, 2026 |
| 3Q26 | $2.302 | +$0.642 | 2 MG | Lorazepam injection | v1, posted September 15, 2026 |
| 2Q26 | $1.66 | +$0.254 | 2 MG | Lorazepam injection | v1, posted September 15, 2026 |
| 1Q26 | $1.406 | +$0.029 | 2 MG | Lorazepam injection | v1, posted September 15, 2026 |
| 4Q25 | $1.377 | +$0.062 | 2 MG | Lorazepam injection | v1, posted September 8, 2026 |
| 3Q25 | $1.315 | −$0.25 | 2 MG | Lorazepam injection | v1, posted March 10, 2026 |
| 2Q25 | $1.565 | +$0.214 | 2 MG | Lorazepam injection | v1, posted March 10, 2026 |
| 1Q25 | $1.351 | −$0.105 | 2 MG | Lorazepam injection | v1, posted December 19, 2025 |
| 4Q24 | $1.456 | +$0.149 | 2 MG | Lorazepam injection | v1, posted June 11, 2025 |
| 3Q24 | $1.307 | +$0.345 | 2 MG | Lorazepam injection | v1, posted June 11, 2025 |
| 2Q24 | $0.962 | −$0.16 | 2 MG | Lorazepam injection | v1, posted March 11, 2025 |
| 1Q24 | $1.122 | +$0.112 | 2 MG | Lorazepam injection | v1, posted December 19, 2024 |
| 4Q23 | $1.01 | +$0.158 | 2 MG | Lorazepam injection | v1, posted October 10, 2024 |
| 3Q23 | $0.852 | −$0.327 | 2 MG | Lorazepam injection | v1, posted June 5, 2024 |
| 2Q23 | $1.179 | +$0.273 | 2 MG | Lorazepam injection | v1, posted February 23, 2024 |
| 1Q23 | $0.906 | −$0.051 | 2 MG | Lorazepam injection | v1, posted December 6, 2023 |
| 4Q22 | $0.957 | +$0.216 | 2 MG | Lorazepam injection | v1, posted June 22, 2023 |
| 3Q22 | $0.741 | +$0.015 | 2 MG | Lorazepam injection | v1, posted June 9, 2023 |
| 2Q22 | $0.726 | +$0.008 | 2 MG | Lorazepam injection | v1, posted December 14, 2022 |
| 1Q22 | $0.718 | −$0.063 | 2 MG | Lorazepam injection | v1, posted June 8, 2022 |
| 4Q21 | $0.781 | +$0.026 | 2 MG | Lorazepam injection | v1, posted June 2, 2022 |
| 3Q21 | $0.755 | +$0.045 | 2 MG | Lorazepam injection | v1, posted June 2, 2022 |
| 2Q21 | $0.71 | −$0.006 | 2 MG | Lorazepam injection | v1, posted March 1, 2022 |
| 1Q21 | $0.716 | – | 2 MG | Lorazepam injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021